Erlangen Stroke Registry: A long-running look at stroke in a German community
Official title: The Erlangen Stroke Registry (ESPro)
Run by University of Erlangen-Nürnberg Medical School · NCT07771335 · Data updated 2026-11-12
This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 17000 (estimated) |
| Sponsor | University of Erlangen-Nürnberg Medical School Academic / other |
| Locations | 3 sites (Erlangen and 2 other locations) |
| Status | Recruiting |
| Started | April 1, 1994 |
| Main results expected | March 30, 2094 |
| Study ends | March 30, 2094 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07771335 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are residents of Erlangen who experience a stroke (as defined by WHO criteria) and are diagnosed within the defined population during the registry period.
✕Probably not a fit
Patients with transient symptoms (<24 hours) or asymptomatic imaging findings are not included and would not directly benefit from this registry data collection.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Erlangen Stroke Registry (ESPro) is a population-based observational registry that has tracked stroke cases in Erlangen, Germany since 1994. It includes both hospitalized and non-hospitalized stroke patients, with long-term follow-up, to document epidemiology, clinical course, and care patterns. The registry aims to inform health planning by providing comprehensive, real-world data on incidence, management, and outcomes of stroke and related conditions such as dementia. Data are drawn from regional hospitals and community sources to capture as complete a picture as possible of stroke in this defined population.
Why it matters
Potential benefit: If successful, the registry could improve understanding of stroke burden and inform resource planning and policy decisions in Germany.
How similar studies have gone: Prior population-based stroke registries have provided valuable epidemiologic insights and informed care planning in several regions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* All cases of stroke defined according to WHO criteria, as "rapidly developing clinical symptoms and/or signs of focal, and at times global, loss of cerebral function, with symptoms lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin occurring in Erlangen, Bavaria
* No restrictions regarding age (provided they are of legal age), socioeconomic circumstance, stroke severity, or prior health status
Exclusion Criteria:
* Patients with transient episodes lasting less than 24 hours and those with asymptomatic lesions detected by brain imaging ("silent infarcts")
Where it's running
-
Malteser Waldkrankenhaus St. Marien
Erlangen, Germany Recruiting -
Universitätsklinikum Erlangen
Erlangen, Germany Recruiting -
Klinikum am Europakanal
Erlangen, Germany Recruiting
Study contacts
- Study coordinator: Peter L. Kolominsky-Rabas, Univ.-Prof. Dr. med.
- Email: peter.kolominsky-rabas@fau.de
- Phone: +49 9131 85-35855
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Early Identification of BAD-related Stroke in Adults
This study tests how well a multisource AI diagnostic approach can identify BAD-related stroke among adults with acute ischemic stroke within a week of onset.
-
HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke
We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.
-
Minocycline for moderate acute stroke at Maimonides
This study will see if adding minocycline to standard care helps adults with moderate acute ischemic or hemorrhagic stroke recover better and survive more often.
-
Prognostic model for neurocritical patients using multimodal brain monitoring
This study tests a model that uses EEG, TCD, and NIRS data to predict 90-day outcomes (awake, coma, or death) in adults with acute brain injuries in intensive care.
-
Binaural ear vagus nerve stimulation for sensory and motor problems after stroke
This trial will test whether synchronized electrical stimulation of the vagus nerve in both ears helps adults who recently had an ischemic stroke improve movement and feeling in affected limbs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.